Parallel Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 184 shares of IOVA stock, worth $1,497. This represents 0.0% of its overall portfolio holdings.

Number of Shares
184
Previous 313 41.21%
Holding current value
$1,497
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$7.28 - $11.9 $939 - $1,535
-129 Reduced 41.21%
184 $1,000
Q2 2024

Aug 08, 2024
BUY
$7.78 - $14.19 $1,594 - $2,908
205 Added 189.81%
313 $2,000
Q4 2023

Feb 09, 2024
SELL
$3.3 - $8.89 $1,574 - $4,240
-477 Reduced 81.54%
108 $0
Q3 2023

May 20, 2024
BUY
$4.44 - $8.79 $1,704 - $3,375
384 Added 191.04%
585 $2,000
Q3 2023

Nov 13, 2023
BUY
$4.44 - $8.79 $1,704 - $3,375
384 Added 191.04%
585 $2,000
Q2 2023

May 20, 2024
SELL
$5.36 - $9.06 $187 - $317
-35 Reduced 14.83%
201 $1,000
Q2 2023

Aug 04, 2023
SELL
$5.36 - $9.06 $187 - $317
-35 Reduced 14.83%
201 $1,000
Q1 2023

May 20, 2024
BUY
$5.53 - $8.22 $707 - $1,052
128 Added 118.52%
236 $1,000
Q1 2023

Apr 25, 2023
BUY
$5.53 - $8.22 $88 - $131
16 Added 7.27%
236 $1,000
Q4 2022

Feb 03, 2023
SELL
$5.62 - $10.0 $1,775 - $3,160
-316 Reduced 58.96%
220 $1,000
Q3 2022

Nov 10, 2022
BUY
$9.53 - $13.11 $247 - $340
26 Added 5.1%
536 $5,000
Q2 2022

Aug 01, 2022
BUY
$6.38 - $18.33 $1,607 - $4,619
252 Added 97.67%
510 $6,000
Q1 2022

Apr 28, 2022
SELL
$12.38 - $19.1 $4,890 - $7,544
-395 Reduced 60.49%
258 $4,000
Q4 2021

Jan 20, 2022
SELL
$16.55 - $27.63 $612 - $1,022
-37 Reduced 5.36%
653 $12,000
Q3 2021

Nov 02, 2021
BUY
$20.35 - $26.63 $6,796 - $8,894
334 Added 93.82%
690 $17,000
Q2 2021

Aug 06, 2021
BUY
$16.33 - $33.07 $4,523 - $9,160
277 Added 350.63%
356 $9,000
Q1 2021

Apr 23, 2021
BUY
$28.67 - $52.59 $974 - $1,788
34 Added 75.56%
79 $3,000
Q2 2020

Jul 16, 2020
BUY
$27.21 - $41.0 $1,224 - $1,845
45 New
45 $1,000

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email